Search results
Emcure Pharma IPO: Issue subscribed 29% on Day 1 so far; NIIs lead from the front
CNBC Awaaz· 1 day agoA day before the drugmaker's public offer went live, Emcure Pharmaceuticals raised Rs 582.6 crore...
Beryl hurricane heads toward Jamaica after ripping through the Caribbean
Business Standard India· 2 days agoA hurricane warning was in effect for Jamaica, Grand Cayman, Little Cayman, and Cayman Brac. Beryl...
Cochin Shipyard rallies over 4% after unit bags order worth Rs 1,100 crore
Business Standard India· 4 days agoUCSL, under contract terms, will undertake the design and construction of four 6300 TDW dry cargo...
Emcure Pharmaceuticals IPO: Bain Capital backed firm raises ₹582 crore from anchor investors ahead...
Livemint· 2 days agoAccording to the exchange filing, the company has allocated 57,79,850 shares to 48 anchor investors...
Stock market update: Mining stocks mixed as market falls
The Economic Times· 3 days agoThe 30-share BSE Sensex was down 28.01 points at 79448.18
Bulls Charge Ahead: Nifty, Sensex hit new highs on global optimism, rate cut speculation
CNBC Awaaz· 13 hours agoThe Bank Nifty also soared to a fresh record high of 53,357.70 led by ICICI Bank, Kotak Mahindra and...
Emcure Pharmaceuticals raises Rs 583 crore from anchor investors ahead of IPO
CNBC Awaaz· 2 days agoEmcure Pharmaceuticals IPO | Marquee global investors including Abu Dhabi Investment Authority,...
Emcure Pharmaceuticals IPO: Check subscription on Day 1, GMP and other details - The Economic Times
The Economic Times· 1 day agoThe initial public offer (IPO) of Emcure Pharmaceuticals, which opened earlier today, was booked 66%...
MC Exclusive: Bansal Wire’s IPO anchor book includes HDFC Mutual Fund, SBI MF, East Spring...
CNBC Awaaz· 2 days agoThe Rs 745-crore IPO, comprising fresh issue of shares, will open for subscription on July 3.
Bain Capital-backed Emcure Pharma mobilises Rs 583 cr from anchor investors
The Economic Times· 2 days agoEmcure Pharmaceuticals has allocated 57.8 lakh equity shares to 48 funds at the upper end of the IPO...